Health Products

Riva-Quetiapine 300 mg

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety, Contamination
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDosage formDIN, NPN, DIN-HIMStrength
Bottle size: 100 tabs
Recalling Firm
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
Marketing Authorization Holder
Laboratoire Riva Inc.
660 Industrial Blvd.
Blainville
J7C 3V4
Quebec
CANADA
A. Riva-Quetiapine 300 mgTabletDIN 02316730300 mg / tablet

Introduction

Recalled products
  1. Riva-Quetiapine 300 mg

Reason

Potential cross-contamination of trace amounts of Clindamycin in Quetiapine Active Pharmaceutical Ingredient during the manufacturing process.

Depth of distribution

Wholesalers and pharmacies in Quebec, Ontario, and British-Columbia
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime